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Background: The use of protons was first suggested for use in treating cancer in 1946, 
due to its preferable dose distribution. In clinical practice, a constant Relative 
Biological Effectiveness (RBE) of 1.1 is used in treatment planning for protons, to 
account for the difference in biological effects between photon and proton irradiation. 
The RBE is, however, known to vary with variables such as physical dose levels, tissue 
type and Linear Energy Transfer (LET). RBE models are generally based on data 
derived from in vitro experiments. 
The aim of this study was to investigate how the restrictions of input data affect the 
estimates of RBE for protons predicted by such models. 
Methods: A database containing 98 in vitro experiments was gathered for this thesis. 
The database was divided into smaller homogenous databases, using the SPSS Two 
Step clustering algorithm. These databases were fitted to common equations for 
𝑅𝐵𝐸𝑚𝑖𝑛 and 𝑅𝐵𝐸𝑚𝑎𝑥. Finally, a Monte Carlo (MC) simulation was performed in order 
to recalculate the dose response in a spread out Bragg peak (SOBP), delivered to a 
planning target volume (PTV), predicted using the obtained RBE limits. 
Results: The cluster analysis divided our database into five clusters of different sizes. 











 for 𝑅𝐵𝐸𝑚𝑎𝑥. Furthermore, the 
recalculations predicted doses in the range of 0.60 to 3.50 Gy(RBE) to the PTV, 
whereas the highest dose values were located in the distal edge of the SOBP.  






seemed to predict the highest doses. High 𝐷𝑚𝑖𝑛 databases also predicted high doses. 
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As of 2018 it was estimated, using the global cancer database  GLOBOCAN 2018, that 
there would be 18.1 million new cases of cancer, and 9.6 million cancer deaths 
worldwide in 2018 [1]. The risk of developing cancer is, according to the American 
Cancer Society, 40% for men and 38% for women. The following risk of dying as a 
result of cancer is for men 22% and for women 19%, meaning that statistically about 
one out of every five people will die as a result of cancer [2]. 
In addition to surgery and chemotherapy, radiotherapy is one of the main modalities 
for treatment of cancer. External beam radiotherapy can be divided into two main 
categories: photon therapy and particle therapy. Photon therapy makes use of high 
energy X-rays, i.e. photons, while particle therapy utilizes massive particles such as 
protons and carbon ions to kill the tumour cells.  
The goal of radiotherapy is to kill or sterilise the tumour cells using ionizing radiation, 
while, as far as possible, sparing the healthy tissue surrounding the tumour. Cells are 
mainly killed or inactivated through damage to the DeoxyriboNucleic Acid (DNA) in 
form of single strand breaks (SSB) or double strand breaks (DSB) to the helical 
structure of the DNA. Protons are, in general, better than photons at producing non-
reparable damage to the DNA structure. 
The interest of radiotherapy using protons has recently spiked in Norway as two proton 
centres are under planning, one in Bergen and one in Oslo. Treatment with protons is 
planned to start in 2024 [3]. 
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1.1 Radiotherapy (Photon therapy) 
In 1895, the German physicist Wilhelm Conrad Röntgen discovered the phenomenon 
which he later termed X-rays, and its use as treatment for breast cancer was put in 
action by Emil Herman Grubbe only a year after this discovery [4]. Following the 
discovery, radiotherapy has increasingly been used to treat cancerous diseases either 
by itself or in combination with surgery or other medicinal treatments. 
Radiotherapy (RT), also known as radiation therapy, is treatment primarily used to treat 
cancer. The goal of radiotherapy is to irradiate the tumour using massive particles, such 
as protons or electrons, or high-energy photons. Ideally killing the tumour cells, while 
sparing healthy tissue.  
Sparing healthy tissue completely is not feasible, and side effects will therefore always 
be a problem. These side effects differ from person to person and depend on several 
factors, such as the type of cancer treated, the delivered dose, the general health of the 
patient and the location of the tumour relative to healthy organs. Examples of side 
effects from radiotherapy can be skin problems in the form of e.g. itching and 
blistering, fatigue and more severely, organ failure or the development of a secondary 
cancer. More location specific side effects can be nausea, hair loss and tooth decay in 
the head and neck region, difficulties swallowing and shortness of breath in the chest 
region, and diarrhoea and rectal bleeding in the pelvis region [5, 6]. 
An important aspect of RT research is to increase the so-called “therapeutic ratio”, also 
known as the “therapeutic window”. This is the ratio of the probability of controlling, 
or eradicating, cancerous cells in a patient, called the tumour control probability (TCP), 
and the probability of harming normal tissue in the process, called the normal tissue 
complication probability (NTCP). Technological advances, such as applying advanced 
imaging techniques to cover the intended area more precisely, or the implementation 
of fractionated dose deliveries to allow more recovery time for healthy tissue, have 
helped increasing the therapeutic ratio. Another modality that can help increase the 
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therapeutic ratio is the use of proton beams to kill the tumour, as a proton beam has an 
advantageous dose distribution [7]. 
1.2 Proton therapy 
The idea of using protons to treat cancer was first suggested by Robert Wilson in 1946, 
with the main motivation being the protons’ preferable dose distribution. The protons 
deposit a low dose in the proximal region of the beam path, followed by a high rise in 
dose deposited to a peak, before consecutively falling to zero. This peak in energy 
deposit is called the Bragg Peak (BP). The BP is advantageous, because it means a 
lower integral dose is delivered to healthy tissue compared to photon based therapies, 
and also the fact that the dose deposition falls to zero after the BP make it advantageous 
close to vital Organs at Risk (OARs). 
It is generally agreed that the biological effects of photon, and proton radiation is 
different, even at the same dose levels. To account for this difference, a scaling factor 
called the Relative Biological Effectiveness (RBE) is used. Clinically a constant RBE 
of 1.1 is used, even though cell survival data shows that this is not always correct, 
especially for high linear energy transfer (LET) values. RBE models have been created, 
that uses the knowledge we have from photons to predict the effect of protons, to 
account for the effects of a variable RBE. Most of these models are phenomenological, 
meaning that they are based on empirical data through some sort of regression. 
As a result, the same described dose could be given to the tumour with particle therapy, 
while the dose to healthy tissue would be significantly lower compared to the 




1.3  Project objectives/motivation 
Cell survival experiments where cells are irradiated at different dose levels, and 
different LET values, form the basis for modelling of the RBE of protons, representing 
the increased effect of protons compared to the standard radiotherapy with photons. 
Previously performed cell experiments vary in the range of doses the cells were 
exposed to, types of cells irradiated, and experimental set-up, influencing e.g. the LET 
distribution. 
RBE models are generally derived by fitting experimental data, derived from cell 
survival experiments, to an equation using some form of regression algorithm. 
Research has, however, suggested that the upper and lower extreme RBE boundaries 
implemented in these models are dependent on the varying ranges of input data 
included in their database. 
In this thesis, we wished to further research the effects restrictions on the database have 
on the model estimations of the RBE. We wish to use cluster analysis to group similar 
cell survival experiments to investigate any trends in the RBE boundaries, 𝑅𝐵𝐸𝑚𝑖𝑛 and 
𝑅𝐵𝐸𝑚𝑎𝑥, as these previously have been shown to be dependent on their input database 
[8]. 
 A sizable database of experimental cell survival data was gathered for this study. The 
database was divided into smaller homogenous databases using a cluster analysis 
algorithm. These smaller databases were further fitted to common 𝑅𝐵𝐸𝑚𝑖𝑛 and 
𝑅𝐵𝐸𝑚𝑎𝑥 definitions, used in RBE models. These refits were then compared to each 
other, and existing RBE models, in order to identify how the input data of the database 




2. Theory of particle therapy 
2.1 Interactions with matter 
A substantial part of this thesis is based on comparison of photon and proton radiation, 
therefore a short introduction to how these particles interact with matter is provided in 
this chapter. 
2.1.1 Photon interaction with matter 
Photons are massless, neutrally charged packs of energy. As photons traverse matter, 
they can interact to produce free electrons by three main processes: the photoelectric 
effect, Compton scattering and pair production [9, 10]. Through the photoelectric 
effect, the photon is absorbed by an atomic orbital electron, which is in turn ejected 
from the atom. In Compton scattering, or incoherent scattering, the photon interacts 
with an atomic electron as if it were “free”, meaning that the electron binding energy 
is significantly lower than the energy of the incident photon. Further the photon hits 
the “free” electron, passing on a portion of its energy and emitting the electron at an 
angle. Pair production can only occur if the incident photon has an energy of at least 
twice the rest mass of an electron (1.022 𝑀𝑒𝑉). The photon interacts strongly with the 
electromagnetic field of the atomic nucleus and spontaneously annihilate into an 
electron-positron pair [9, 10]. In clinical radiotherapy photon energies of about 4-22 
MV are used. In this range the Compton Effect is dominating, as can be interpreted 
from Figure 1.  
In these processes free electrons are created, and it is these secondary particles that are 
responsible for most of the biological damage in photon therapy. Hence, photons are 
often referred to as indirectly ionizing particles. 
A photon beam will decrease in intensity as it traverses the absorbing medium. The 
mathematical description of photon intensity, as a function of distance travelled in an 
absorbing medium, 𝐼(𝑥), is given as: 
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 𝐼(𝑥) = 𝐼0𝑒
−𝜇𝑥 (1) 
Where 𝐼0 is the photon intensity before the beam enters the medium, 𝑥 is the distance 
traversed in the medium by the beam and 𝜇 is the linear attenuation coefficient of the 
target material [9, 10]. The linear attenuation coefficient is also called macroscopic 
cross section, which in turn reflects the probability of a certain process to occur [10]. 
Which of the processes will occur is highly dependent on the energy of the photon as 
seen in Figure 1. The density (𝜌) and atomic number (𝑍) of the target material also 
affect the probability of the different processes. 
 
Figure 1: Linear attenuation coefficient versus photon energy for the relevant photon 
interaction processes [11]. 
This thesis uses photon radiation as a reference to the radiation of protons. 
 
2.1.2 Proton interaction with matter 
A proton is a heavy, positively charged particle. A heavy particle has a significant rest 
mass compared to the rest mass of an electron. Protons interact with matter primarily 
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through three mechanisms: Coulomb interactions with orbital electrons, Coulomb 
interactions with nuclei, and nuclear interactions [9, 12, 13].  
In Coulomb interactions with orbital electrons, the proton hits an orbital electron and 
transfers a fraction of its energy to it. The electron can be excited to a higher shell or, 
if the energy transferred is high enough, the electron can escape the atom all together, 
creating an ion-pair. This process is the main contributor to the energy loss of the proton 
beam. The secondary electrons that escape their original atom are called delta-rays and 
will ionize and deposit energy a short distance from the protons’ path. As the proton is 
far heavier than an electron, the proton’s path will not be affected much from a single 
interaction [12]. 
If a proton travels close to a nucleus at a shallow angle it will be repulsed by the 
Coulomb force, since both the nucleus and the proton is positively charged. Through 
this interaction the direction of the proton beam will change slightly, however, the 
proton will not lose any energy [12]. Although this does not affect the proton beam 
significantly, if it occurs several times in the proton’s path it can lead to non-negligible 
lateral spreading of the beam. This is called “multiple Coulomb scattering” [12]. 
Finally, the proton can interact directly with the nucleus if the angle of approach is 
narrow. A large portion of energy is then transferred to the nucleus from the incident 
proton, which can lead to scattering at a large angle. Nuclear scattering can be either 
elastic or non-elastic. In elastic nuclear scattering the nucleus will recoil, and the total 
kinetic energy will be preserved. In non-elastic nuclear scattering, the energy 
transferred from the proton to the nucleus can lead to secondary events such as 
disintegration of the nucleus into smaller fragments or the emission of prompt gamma 
rays. If the nucleus recoils, the proton will be absorbed at the point of interaction, which 
will also happen to heavier fragments of a reduced nucleus. The scattered protons and 
secondary neutrons can travel a relatively large distance from the point of interaction, 
creating a “halo” of low dose deposition [12]. 
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An illustration depicting the processes for proton interactions with matter is shown in 
Figure 2. 
 
Figure 2: Illustrations of the main processes describing proton interactions with matter: (a) 
Coulomb interaction with orbital electrons, (b) Coulomb interaction with a nucleus, and (c) 
nuclear interaction [13]. 
 
2.1.3 Dosimetry 
The measure of energy absorbed by an irradiated material is called absorbed dose. Dose 
is used for all types of ionizing radiation, all materials, and all energies, and it is the 






Where 𝑑𝜖 is the mean energy deposited to a material of mass 𝑑𝑚. The unit of the 





2.1.4 Depth-Dose profile 
Photon beams have a depth-dose curve that rises towards a maximum in the so called 
dose build-up region [9], before gradually decreasing, as can be seen in Figure 3. The 
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rise in dose is due to the production of free electrons through photoelectric effect, 
Compton scattering or pair production. The position of the dose maximum is dependent 
on the photon beam energy but is generally in radiotherapy located a few centimetres 
into the patient. The decrease in dose deposition, following the maximum, stem from 
the attenuation of the photon beam [9].  
Protons, on the other hand, have a significantly longer build-up region. The dose 
deposited increases exponentially until it reaches a narrow maximum, the Bragg Peak 
(BP). Distal to the BP, the dose falls rapidly to zero. The shape is a result of the stopping 
power for protons, as explained by equation (3), which is inversely proportional to the 
velocity squared. In the shallow region, where the proton beam has the highest velocity, 
the deposited dose will be lowest. When the beam becomes attenuated, thus slowed 
down, the absorbed dose will increase until the velocity reaches zero and the protons 
are completely absorbed in the BP. The Depth-Dose profile is one of the main 
arguments for proton therapy over photon therapy. Heavier ions such as Carbon nuclei 
have a similar Depth-Dose curve to protons, but with a sharper BP. However, because 
heavier ions can be broken down into smaller fragments, a distal “tail” of dose is also 
deposited beyond the BP. This can lead to complications if the tumour is located close 
to an OAR. 
By irradiating several times with different proton energies, dose can be deposited 
homogeneously to a larger area to form a Spread-Out Bragg Peak (SOBP). The Depth-
Dose profiles of a photon beam, a monoenergetic proton beam and a SOBP proton 




Figure 3: Depth dose profile of photons (black), monoenergetic protons (blue) and a Spread 
Out Bragg Peak (SOBP) (red) as a result of several monoenergetic irradiations [14]. 
 
2.1.5 Stopping power 
As protons and other heavy charged ions travel through a medium they mainly lose 
energy due to collisions with orbital electrons (Chapter 2.1.2). Despite each individual 
collision contributing to a very small amount of energy lost, because of the high 
frequency of interactions per unit length, the loss of energy as a function of distance 
travelled becomes substantial. The energy lost by the particle to this effect per unit 
length traversed is known as electric stopping power and is described by the Bethe-



















The variables in the Bethe-Bloch formula is described in Table 1. 
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The correction terms at the end of the Bethe-Bloch formula (𝛿 and 𝐶) arise from 
relativistic theory and quantum mechanics and only become significant when very high 
or very low proton energies are used. From Equation (3) it can be seen that the stopping 
power is not dependent on the mass of the proton, but is proportional to the proton 
charge squared and inversely proportional to the proton velocity squared. 
Table 1: Description, value, and unit of Bethe-Bloch variables.  
Variable Description Value and unit 
𝒅𝑬 Change in energy  
𝒅𝒙 Small part of particle track  
𝑵𝒂 Avogadro’s constant 6,022 ∗ 10
23𝑚𝑜𝑙−1 
𝒓𝒆 Electron radius 2,818𝑓𝑚 
𝒎𝒆 Electron mass 0,511𝑀𝑒𝑉/𝑐  
𝒄 Velocity of light in a vacuum 2,998 ∗ 108𝑚/𝑠 
𝝆 Mass density of absorbing material 𝑔/𝑐𝑚3 
𝒁 Atomic number of absorbing 
material 
 
𝑨 Atomic mass of absorbing material 𝑔/𝑚𝑜𝑙 
𝒛 Charge of projectile particle (proton) 𝐶 
𝜷 = 𝒗/𝒄 Relativistic velocity of incident 
particle (proton) 
 
𝜸 Lorentz factor = 1/√1 − 𝛽2  
𝒗 Velocity of incident particle (proton) 𝑚/𝑠 
𝑾𝒎𝒂𝒙 Maximum energy transfer from a 
single collision 
 
𝑰 Mean excitation potential absorbing 
material 
𝑒𝑉 
𝜹 Density corrections  
𝑪 Shell corrections  
12 
 
2.1.6 Linear Energy Transfer 
Linear Energy Transfer (LET) is used to describe the ionisation density in a particle 
track as a function of depth travelled in the tissue. LET is strongly depending on the 
energy of the particle, and its unit is 
𝑘𝑒𝑉
𝜇𝑚
. Unrestricted LET (𝐿𝐸𝑇∞) will be the same as 
the stopping power of the particle, restricted LET (𝐿𝐸𝑇Δ), however, excludes the 
secondary electrons with energies over a threshold, Δ [17]. 𝐿𝐸𝑇Δ is given by the 
following equation [18]: 




where 𝑑𝐸Δ is the average loss of energy by the emitted particles as it traverses the tissue 
and 𝑑𝑥 is the traversed distance. 
To better reflect the biological effect of the radiation, the dose averaged LET (𝐿𝐸𝑇𝑑) 









where 𝑆𝑒𝑙(𝐸) is the electronic stopping power of primary charged particles with kinetic 
energy 𝐸, and 𝐷(𝐸, 𝑧) is the absorbed dose contributed by primary charged particles 





𝐿𝐸𝑇𝑑 is proportional to the electronic stopping power, as shown by equation (5), which 
in turn is inversely proportional to the velocity of the beam. Therefore, the 𝐿𝐸𝑇𝑑 will 
drastically increase when the beam slows down at the distal edge the beam track, close 






Figure 4: Dose averaged LET (solid) depth distribution of a monoenergetic proton beam 
with an initial energy of 160 MeV with corresponding dose (dotted) depth distribution 
resulting in a Bragg Peak [20]. 
2.2 Radiobiology 
Radiobiology is the study of the effect of ionizing radiation on living organsims, where 
in this thesis, the effect on tumour and healthy tissue is of interest.  In this chapter, 
some key concepts in radiobiology will be described. 
 
2.2.1 Colonial cell experiments 
The data that was used in this thesis was gathered from in vitro (Latin: in the glass) 
experiments, meaning that cell colonies are grown in petri-dishes, and subsequently 
irradiated. From these experiments, the Survival Fraction (SF) and radiation dose (D) 
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can be found. This process can be repeated for several different dose values. When 
several dose and SF pairs are obtained, they can be plotted in a graph and by regression 
one can create a cell survival curve [21]. By doing this for several types of radiation, 
radiation techniques, and cell lines, several cell survival curves can be created and 
compared, as shown in Figure 5. For in vitro experiments, several cell lines can be 
studied, where the most commonly used are Chinese hamster ovary (CHO) cells. 
The alternative method is in vivo (Latin: within the living) experiments, meaning 
experiments on whole living organisms, such as animals, plants or even humans. Since 
in vivo experiments represent the actual conditions of living organisms, whereas in 
vitro only apply to the specific cells that are being irradiated, it is mostly agreed that in 
vivo experiments are better to represent clinical scenarios. However, as in vitro 
experiments are far easier to perform in a laboratory, and are less likely to harm sentient 
living organisms, in vitro is the method most commonly used today.  
 
Figure 5: Example of cell survival curves derived from irradiation with several different 
doses and LET values [22]. 
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2.2.2 The Linear-Quadratic model 
The linear-Quadratic (LQ) model is a mathematical model used to describe the 
biological response of cells to radiation, by fitting the logarithm of the survival 
fractions as a function of dose from colonial cell experiments, as in Figure 5, to a 
second order polynomial [23]. The survival fraction is here given as: 
 − ln(𝑆𝐹) = 𝛼𝐷 + 𝛽𝐷2 → 𝑆𝐹 = 𝑒(−𝛼𝐷−𝛽𝐷
2) (6) 
where 𝛼 and 𝛽 are tissue specific parameters. The initial slope, and linear component 
of the survival curve is determined by 𝛼. The linear component represents lethal cell 
damage in form of single-track events, in where a single particle from the beam is 
responsible for one complete DSB. The curvature and quadratic component of the 
survival curve, on the other hand, is determined by 𝛽. This represents repairable cell 
damage in form of double-track events, meaning two separate particles from the beam 
are responsible for a SSB each resulting in similar lethal damage to the DNA helix 
[23]. 
The ratio of these tissue specific parameters, 
𝛼
𝛽
, is defined as the dose where the linear 
and quadratic components contribute to the same amount of cell killings. Early 
responding tissue, such as skin and most tumours, has a relatively high 
𝛼
𝛽
 ratio in the 
range 7-20 Gy. Early responding tissue usually expresses damage within days or 
weeks. Late responding tissue has a low 
𝛼
𝛽
 ratio of 0.5 - 6 Gy. Late responding tissue 
expresses damage after several months or even years [23]. An illustration depicting the 








Figure 6: Example of cell survival curves with interpretation of the linear and quadratic 
components of the LQ model as well as their ratio. The straight line depicts a typical survival 
curve for high LET radiation [23]. 
Data suggests that the LQ model fits accurately in the middle dose ranges, however, 
for doses lower than 1-2 Gy [21, 23, 24] and higher than 5-6 Gy [21, 23], some 
modifications to the model could provide a better fit. In the low dose range, the induced 
repair (IndRep) model has been proposed, where both the linear and quadratic 
components of the LQ-model are corrected based on the dose where the cells stop being 
hypersensitive and start becoming more radioresistant [21, 23]. In the high dose region, 
the Linear-Quadradic-Cubic (LQC) model has been proposed. In this model a cubic 
component is added to the LQ-model to correct for the effect of cell overkill on the 
survival fraction [23]. 
In this thesis, only the original LQ-model is regarded. 
2.2.3 Relative Biological Effectiveness 
When comparing different radiation modalities, such as photons, protons, and heavier 
ions, and specifically the difference in their ability to kill cells, the Relative Biological 
Effectiveness (RBE) is used. Clinically a constant RBE of 1.1 is used in treatment 
planning for proton therapy, but there is general agreement that the RBE is not constant 
17 
 
and often higher than 1.1, especially for higher LET values. The general way to 
calculate RBE is by comparing the dosage necessary to kill a certain percentage of the 
cells for two different radiation modalities, thus referring to a specific survival fraction, 
e.g. 𝑆𝐹 = 10%. These dose values can be gathered from cell survival curves (Figure 
5) containing data from the modalities one wants to compare. When comparing protons 
to a reference radiation, e.g. Cobolt-60 𝛾-rays, the equation for RBE based on the 
endpoint survival is given by: 
 𝑅𝐵𝐸(𝐷, 𝑆𝐹 = 10%) =
𝐷 𝐶𝑜60 (𝑆𝐹 = 10%)
𝐷𝑝(𝑆𝐹 = 10%)
 (7) 
where 𝐷 𝐶𝑜60 (𝑆𝐹 = 10%) is the dosage needed by the reference radiation Cobolt-60 to 
kill 90% of the cells and 𝐷𝑝(𝑆𝐹 = 10%) is the dosage needed by the proton radiation 
to kill 90% of the cells. RBE is, as the name indicates, a ratio and is therefore unitless. 
The RBE depends on a number of variables such as absorbed dose, LET, type of 
radiation, radiation quality, e.g. LET, type of cells and endpoint [25-27]. The RBE can 
also be calculated using parameters from the LQ model by the following equation [25, 
28]: 




















where 𝐷𝑝 is the physical dose deposited by the protons, 𝛼 and 𝛽 are the tissue specific 
LQ parameters for the proton and, 𝛼𝑥 and 𝛽𝑥 are the tissue specific LQ parameters for 
the reference radiation. As the RBE is known to be inversely proportional to the dose, 
the maximum and minimum values of RBE is defined to be in the low and high dose 
limits respectively and is given by: 















This can be seen from the LQ-model, where the linear component is clearly dominant 
in the low dose region, while the quadratic component dominates the high dose region.  
By inserting equations (9) and (10) into equation (8), the 𝑅𝐵𝐸 can be written as [29, 
30]: 



























This equation is common for all LQ-based RBE models, however, they differ in their 
definition of 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 [25]. 
To account for the difference in killing efficiency between radiation modalities, 
treatment plans are usually not based on the physical dose, but rather the RBE-weighted 
dose (𝐷𝑅𝐵𝐸), also called biological dose: 
 𝐷𝑅𝐵𝐸 = 𝑅𝐵𝐸 × 𝐷 (12) 
where 𝐷 is the physical (absorbed) dose. The units for biological dose are also Gray 
(𝐺𝑦), however, to distinguish it from the physical dose it is usually written as 
𝐺𝑦(𝑅𝐵𝐸).  
LQ based RBE models are generally derived by calculating the 𝑅𝐵𝐸𝑚𝑖𝑛, and 𝑅𝐵𝐸𝑚𝑎𝑥, 
using equations (9) and (10), then fitting these values to custom equations using a 
regression algorithm. The equation used in this process can vary from model to model, 






the 𝑅𝐵𝐸𝑚𝑎𝑥 is usually shown to be increasing with increasing 𝐿𝐸𝑇𝑑, with a steeper 
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 values. The 𝑅𝐵𝐸𝑚𝑖𝑛 is often assumed to be equal to one [31]. As 
different databases are used to derive these models, and the definitions of 𝑅𝐵𝐸𝑚𝑖𝑛, and 
𝑅𝐵𝐸𝑚𝑎𝑥 differ, the dose distributions recalculated using these models also differ, as 
depicted in Figure 7. 
 
Figure 7: Depth dose distribution of a SOBP in a water phantom recalculated with various 





 of 3.76 Gy was used in the 
calculations [31]. 
   
2.3 Cluster analysis 
A cluster analysis is a tool used to find groups in sets of data [32]. These groups, or 
clusters, are determined only by the information found in the dataset, and the 
relationships within the data. The goal of a cluster analysis is to separate the data into 
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clusters, where the data within a certain cluster is similar (or related) and the data in 
one cluster is different (or unrelated) compared to data in a different cluster [33]. 
Cluster analysis has a wide range of uses. It is used in several fields, such as Biology, 
Business, Climate research, Medicine and Psychology. One of the most famous 
examples of clustering is the Taxonomy of all living things. This is a hierarchical 
classification where each individual species is considered as an original singleton 
cluster. Species are merged into genus based on their shared characteristics. Genus are, 
consecutively, merged into family, then order and after several iterations everything is 
categorized as life in the final cluster [33, 34]. 
Some popular clustering algorithms are K-means clustering, Agglomerative 
Hierarchical clustering and Density-based clustering of applications with noise 
(DBSCAN). K-means clustering demands a user-specified number of clusters (K). K 
initial centroids are then chosen and all datapoints are assigned to the closest centroid. 
New centroids are then computed, and the data is reassigned to its current closest 
centroid. This process is repeated until the centroids remain unchanged between 
iterations. Agglomerative Hierarchical clustering considers every single datapoint as a 
singleton cluster. The two closest clusters are then merged into one and further 
considered as one entry. This process can be repeated as many times as necessary, even 
until every datapoint in the database is merged into a single cluster. DBSCAN is a 
density-based algorithm. Regions in the dataset with a high density of datapoints, 
separated by low-density regions, are defined as a cluster. Low-density regions are, 
however, considered noise and can be omitted by the algorithm [33]. 
Cluster analysis has also been utilized in radiotherapy, for example to classify 
radioresistant and sensitive cell lines [35], segmenting tumour subregions 
(Supervoxels) and grouping these subregions into phenotypic, meaning observably 
distinguishable, clusters [36], and to establish clusters based on combinations of 
treatment options [37]. 
21 
 
3. Material and Methods 
3.1 The database 
A database containing data from 98 in vitro cell survival experiments was collected for 
this project, including a total of 730 discrete data points from proton irradiation. What 
is referred to as an experiment is here one row in the final database, represented by one 
cell survival curve with all coresponding relevant data. The database is based on the 
database used in by Rørvik et al 2019 [8], combined with data from Paganetti et al 
2014 [26] and finally from the Particle Irradiation Data Ensemble (PIDE 3.1) [38] 
database. Firstly, only experiments using proton radiation were included, additionally, 
all non-monoenergetic experiments were excluded. The database was then restricted to 
only contain experiments with 𝐿𝐸𝑇𝑑 values lower or equal to 20
𝑘𝑒𝑉
𝜇𝑚
. An important 
difference from Rørvik’s database, compared to the one used in this thesis, is that 





 values lower or 
equal to 5 𝐺𝑦. This was because Rørvik’s database was representing late responding 
tissue, but for this study that was not the case, so this restriction was removed. 
The database includes information on the type of reference radiation used in the 
experiments, as well as 𝛼- and 𝛽-values for both the reference radiation and the proton 
radiation. The 𝐿𝐸𝑇𝑑 values were provided in both Rørvik’s and Paganetti’s databases 





 , 𝑅𝐵𝐸𝑚𝑖𝑛 and 𝑅𝐵𝐸𝑚𝑎𝑥 values were calculated 
using equations (9) and (10). Finally, the dose values used to irradiate the cells and the 
corresponding cell survival fractions were retrieved from Rørvik and PIDE databases. 
For experiments not included in Rørvik’s or PIDE’s databases, WebPlotDigitizer 
Version 4.2 [39] was used to extract cell survival for different dose levels from curves 
in the relevant papers. 
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The data in our database consists of 98 cell survival curves from the following 27 
papers: Baggio et al 2002 [40], Belli et al 1998 [41], Belli et al 2000 [42], Bettega et 
al 1998 [43], Bird et al 1980 [44], Chaudhary et al 2014 [45], Folkard et al 1996 [46], 
Folkard et al 1998 [47], Fuhrman Conti et al 1988 [48], Green et al 2001 [49], Green 
at al 2002 [50], Guan et al 2015 [22], Hei et al 1988a[51], Hei et al 1988b [52], 
Howard et al 2017 [53], Jaynes et al 2013 [54], Moertel et al 2004 [55], Patel et al 
2017 [56], Perris et al 1986 [57], Petrovic et al 2006 [58], Prise et al 1990 [59], 
Schettino et al 2001 [60], Schuff et al 2002 [61], Sgura et al 2000 [62], Slonina et al 
2004 [63], Wainson et al 1974 [64], and Wera et al 2013 [65]. 
The database includes experiments using the following photon reference radiations: 
60Co, 137Cs, 6 MV photons, 120 kVp x-rays, 200 kVp x-rays, 225 kVp x-rays, 240 kVp 
x-rays, 250 kVp x-rays and 300 kVp x-rays. As correcting RBE directly from the 
reference radiation is not feasible [26], the 𝐿𝐸𝑇𝑑 values were normalized to Cobalt-60 
instead using the following equation [25, 66]: 
 𝐿𝐸𝑇
∗ =  𝐿𝐸𝑇𝑝 − 𝐿𝐸𝑇𝑥 + 𝐿𝐸𝑇 𝐶𝑜60  (13) 
Where 𝐿𝐸𝑇∗ is the normalized 𝐿𝐸𝑇𝑑 value, 𝐿𝐸𝑇𝑝 is the 𝐿𝐸𝑇𝑑 value of the proton beam 
in each experiment, 𝐿𝐸𝑇𝑥 is the 𝐿𝐸𝑇𝑑 value of the reference radiation used in the 
corresponding experiment and 𝐿𝐸𝑇 𝐶𝑜60  is the 𝐿𝐸𝑇𝑑 value of 𝐶𝑜
60 . The 𝐿𝐸𝑇𝑥 values 
used for normalisation are listed in Appendix A. 
3.2 Cluster analysis 
We wished to investigate the effect the ranges of the input data have on the RBE 
modelling process. To achieve this, our database was divided into smaller fractions 
with similar experimental data within each fraction [67]. 
A cluster analysis was performed on the data set using the Two-Step clustering 
algorithm in the IBM SPSS® Statistics software version 25. Two-Step clustering has 
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as the name indicates two steps, a non-hierarchical and a hierarchical step. First, in the 
non-hierarchical part, or sequential algorithm, the algorithm runs through all the 
experiments in the database in order, it then adds the current experiment to an existing 
pre-cluster if the distance measure chosen for the algorithm is within a threshold 
distance determined by the algorithm. If it is not, the algorithm creates a new pre-cluster 
and adds the experiment to it. Since this step depends on the order the input is read, the 
data was randomized prior to running the algorithm. The pre-clusters are considered 
the input to the hierarchical part of the algorithm, and cannot be split into different 
clusters during this step [68].  
Early in the project, it was not yet decided if categorical variables, e.g. the type of 
reference radiation, would be included as an input variable. A distance measure of Log-
Likelihood distance was, therefore, chosen for this cluster analysis, because it could be 
used for both continuous, and categorical variables, in case of changes in the choice of 
input variables. The Log-Likelihood distance measure between two clusters is related 
to the decrease in Log-Likelihood as they are merged into one cluster. The distance 
between clusters a and b, 𝑑(𝑎, 𝑏), are calculated in SPSS by the following equation: 
 𝑑(𝑎, 𝑏) = 𝜉𝑎 + 𝜉𝑏 − 𝜉<𝑎,𝑏> (14) 
Where: 












Here 𝑁𝑣 is the number of data records in cluster 𝑣, ?̂?𝑘
2 is the estimated variance of the 
kth variable across the entire dataset, ?̂?𝑣𝑘
2  is the estimated variance of the kth variable 
in cluster 𝑣. 𝐾𝐴 and 𝐾𝐵  represent the total number of continuous and categorical 
variables, respectively. As we did not use any categorical variables in our analysis the 
summation to the right in equation (15) can be neglected. The notation < 𝑎, 𝑏 > 
describes a merged cluster consisting of the previously separate clusters 𝑎 and 𝑏 [68]. 
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The variables used to create the clusters were the 𝛼- and 𝛽-values from the proton 
radiation, the  normalized 𝐿𝐸𝑇𝑑-value and the lowest dose from each cell line in the 
data set, 𝐷𝑚𝑖𝑛. The (
𝛼
𝛽
) from the reference radiation as well as the 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 
values, were used as additional evaluation fields during the analysis in order to spot 
trends within these variables based on the cluster distributions. An evaluation field is a 
variable which is not used to determine the cluster memberships, however considered 





 was not included as an input variable, because 
the same reference radiation was used in several experiments, and therefore, if it would 
be used to determine the cluster memberships, the clusters could be determined by 





 would be a so called swamping variable. A 
swamping variable is a variable that essentially hijacks the clustering when it comes to 
cluster membership partitioning. The 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 values were not included 
as input variables, because we wanted to find trends in these variables based on the cell 
survival data included in the database. 
To determine the ideal amount of clusters, a combination of Akaike Information 
Criterion (AIC) [69] and a silhouette score was used. AIC is an estimation of 
information lost in a model, where a low AIC value translates to little information lost, 
and a high AIC value indicates a high amount of lost information. The AIC value for a 
model with 𝐽 clusters is calculated by SPSS using the following equation: 
 𝐴𝐼𝐶(𝐽) = −2𝑙𝐽 + 2𝑚𝐽 (16) 
Where 𝑚𝐽 is the number of independent parameters, and: 




where again 𝑣 and 𝜉𝑣 are from Equation (15) [69-71], and: 
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 𝑚𝐽 = 𝐽 (2𝐾





An alternative to AIC was the Schwarz’s Bayesian information criterion (BIC). This is 
calculated by SPSS with the following equation: 
 𝐵𝐼𝐶(𝐽) = −2𝑙𝐽 + 𝑚𝐽log (𝑁) (19) 
 
Where 𝑁 is the total number of experiments in the analysis, 𝑙𝑗 is given by equation (17), 
and 𝑚𝑗 is given by equation (18).  
Similar to Equation (15) the righthand sum within the parenthesis can be neglected as 
no categorical variables were used [68]. It is believed that BIC is slightly inferior to 
AIC [70, 72, 73], therefore AIC was most heavily considered when deciding the 
preferable number of clusters in the analysis. BIC was included for comparison. 
The silhouette score describes how similar the data within a cluster is, compared to all 





where 𝐴 is the average distance between a given datapoint and the centroid of the 
cluster the datapoint is in, and 𝐵 is the smallest average distance between the same 
datapoint to the centroid of other clusters [33, 68, 74, 75]. A silhouette score ranges 
between -1 and 1, where 1 translates to a perfect model, however, an average silhouette 
score of higher than 0.5 is regarded as a “good” model and a score between 0 and 0.5 
is considered a “fair” model. A model is considered as “bad” if its silhouette score is 
lower than zero [32, 68]. The average Silhouette score of each individual datapoint is 
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what is considered in the final model. Silhouette scores are only applicable for models 
with two or more clusters. 
When deciding the ideal number of clusters, the Predictor Importance was also taken 
into consideration. Predictor Importance is a measure of the ability of a variable to 
differentiate clusters. A high Predictor Importance value indicates that the variation in 
the variable is caused by an underlying difference rather than mere chance. The 
Predictor Importance value (𝑉𝐼𝑖) is normalized so that the highest value is one, and 







where Ω is the set of variables and evaluation fields, 𝑠𝑖𝑔𝑖  is the significance or 𝑝-value 
of variable 𝑖, determined by applying the F-test for continuous fields and Pearson’s chi-
square for categorical fields, such as reference radiation [32, 68]. In contrast to the 
silhouette score, the predictor importance does not have numerical definitions where it 
is defined as “good” or “bad”. However, a model where the predictor importance of 
each variable is close to equal and close to one is preferred. 
AIC values for 1 to 15 clusters, and Silhouette scores for 2 to 15 clusters were 
calculated and plotted to select the ideal number of clusters. BIC values were also 
calculated and plotted for comparison. For the number of clusters deemed ideal given 
the evaluation parameters, the clusters were plotted and compared. In addition to the 






, 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛. 
Based on the results of this analysis, a secondary cluster analysis was performed where 
four extreme values were excluded, because they do not represent clinically relevant 
cells and dose deliveries. One experiment from Petrovic et al [58] was excluded for its 
unusually high 𝐷𝑚𝑖𝑛 value of 8.015 𝐺𝑦. Another Cell survival curve from Baggio et al 
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 value was 69.5 𝐺𝑦 , which is significantly higher 
than typical clinical values. The final experiments excluded were two cell survival 
curves from Schuff et al [61], because of their extremely low reference 𝛼 value of 





 value of 0.051 𝐺𝑦 and 𝑅𝐵𝐸𝑚𝑎𝑥 values 
of 35 and 80, respectively. Thus, the final database ended up comprised of 94 
experiments. 
3.3 Model comparison 
Eleven existing RBE models were compared to the clusters from the analysis 
performed in this study. The following models were compared: Belli et al 1997 [76], 
Wilkens and Oelfke et al 2004 [28], Tilly et al 2005 [67], Chen and Ahmad et al 2012 
[77], Carabe et al 2012 [78], Wedenberg et al 2013 [79], Jones et al 2015 [80], 
McNamara et al 2015 [81], Mairani et al 2017 [82], Rørvik et al 2017 [25] and Peeler 
et al 2016 [83]. 
The comparison was done to see if any of the clusters would be over- or 
underrepresented in any of the models, and to find out if any trends in the models are 
in agreement with the cluster model. 
3.4 RBE modelling/estimation 
To further investigate trends in the database, the curve fitting tool in MATLAB version 
R2018a (MathWorks, Natick, MA, USA) [84] (cftool()) was utilized to fit the 
datapoints to the 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 model equations: 















Where 𝑐𝑚𝑖𝑛 and 𝑐𝑚𝑎𝑥 are the fitting variables of the resulting models. The custom 
equation option in cftool() was utilized to fit the data to the relevant equation. 
The 𝑅𝐵𝐸𝑚𝑖𝑛, as mentioned earlier, is often assumed to be equal to one. However, to 
investigate if this is a valid simplification, we decided to fit it to an equation linearly 
dependent on the 𝐿𝐸𝑇𝑑. If the assumption is valid, we would expect fitting variables 
close to zero. The trends for 𝑅𝐵𝐸𝑚𝑎𝑥 are generally, as mentioned in Chapter 2.2.3, 





 values. The general 
form of equation (23) is the most frequently used equation to fit 𝑅𝐵𝐸𝑚𝑎𝑥 to , however, 
some models choose to let the regression algorithm decide the constant term, instead 
of setting it to one. Relevant model equations can be found in Appendix C.  
Both the 𝑅𝐵𝐸𝑚𝑖𝑛 and 𝑅𝐵𝐸𝑚𝑎𝑥 were fitted to datapoints in each of the five clusters. A 
final curve fit using all datapoints was also performed. This model is throughout the 
rest of the thesis referred to as the “All clusters” model. 
To represent “Goodness of fit” the R-squared values were utilized. This statistic 
represents the relative fraction of variation about the average in the data, that can be 
explained by the model. An R-squared value is normally between one and zero, where 
a value of one means that all variation can be explained by the model. The 95% 
confidence interval was included as a measure of margin of error. 
3.5 FLUKA simulation and dose calculations 
We further wish to investigate the dose and RBE distributions resulting from the 
different clusters found in this thesis to see if the data included in each model/cluster 
led to differences in dose, RBE and hence biological damage. 
29 
 
An existing proton treatment plan created in the Eclipse treatment planning system 
(Varian Medical Systems, Palo Alto, CA, USA) was provided. This plan was designed 
to deliver a dose of 2 𝐺𝑦(𝑅𝐵𝐸) to a planning target volume (PTV) within a water 
phantom, assuming an RBE of 1.1 as is used in current clinical practice. The treatment 
plan information was given in Digital Imaging and Communications in Medicine 
(DICOM) format and included information such as CT images of the water phantom, 
a 4 𝑐𝑚 × 4 𝑐𝑚 × 4 𝑐𝑚 PTV, and treatment field specific information such as gantry 
angle and beam energy. Using an in-house Python script [85], the treatment plan 
information was converted into a format readable for the FLUKA Monte Carlo (MC) 
code [86, 87] called an input file. FLUKA also has a graphical user interface called 
FLAIR (FLUKA Advanced Interface) [88] which can be used to further set up the 
simulation environment. As FLUKA cannot read the DICOM CT images directly, 
FLAIR was used to convert the images into a so-called voxel file. This file contains 
material and density information for each voxel and was used during the simulations. 
An executable file was created using the source and fluscw FLUKA user routines. The 
source routine reads specific information from the treatment field such as spot 
positions, spot sizes and beam divergence. As FLUKA and the DICOM format 
employs different coordinate systems, the information was converted into FLUKA 
format by the source routine. The fluscw routine was also used to obtain physical 
parameters such as the LET as well as to calculate the dose given by 
𝑓𝑙𝑢𝑒𝑛𝑐𝑒 × 𝐿𝐸𝑇/𝜌, where 𝜌 is the density of the material. We used a homogenous 
water phantom, so 𝜌 is here the density of water, 1 𝑔/𝑐𝑚3 [85, 89]. The irradiation of 
the water phantom was simulated using 106 primary particles, creating scoring files 
for dose and LET in ASCII format. For all simulations, FLUKA version 2011.2x.8 and 
FLAIR version 2.3-0 was used. 
Furthermore, the ASCII files created by the FLUKA simulation were converted back 
into DICOM files to make them compatible with the scripts used to create plots. In this 
process the biological dose for 𝑅𝐵𝐸 = 1.1, 𝐿𝐸𝑇𝑑, and the unweighted Rørvik [25] 
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model were exported along with the cluster models created in this thesis. The 
unweighted Rørvik model was chosen because of its high amount of common 
datapoints with our database. This conversion process essentially recalculated the dose 
within each voxel using equation (11) where 𝐷𝑝 is the dose calculated based on the 
fluence, and 𝑅𝐵𝐸𝑚𝑖𝑛 and 𝑅𝐵𝐸𝑚𝑎𝑥 originated from the relevant models. The 𝑅𝐵𝐸 =
1.1 model assume a 𝑅𝐵𝐸𝑚𝑖𝑛 = 𝑅𝐵𝐸𝑚𝑎𝑥 = 1.1. The model equations for the Rørvik 
unweighted model can be found in Appendix C, and the model equations for the cluster 





= 2 𝐺𝑦, 
representing late responding tissues, and the 𝐿𝐸𝑇𝑑 values  used to calculate 𝑅𝐵𝐸𝑚𝑖𝑛 
and 𝑅𝐵𝐸𝑚𝑎𝑥 within each voxel were directly obtained from the FLUKA simulations. 
These new recalculated DICOM files were subsequently used to plot the dose and RBE 
distributions along with the 𝐿𝐸𝑇𝑑 distribution. 
Cumulative Dose Volume Histograms (DVHs) were then created based on the 
recalculated DICOM files. In a cumulative DVH, the height of each bin along the x-
axis represent the relative volume of the chosen structure that receives an equal or 
greater dose [9]. 
Throughout this process, existing in-house scripts from our group, with some project 
specific modifications, were used. The scripts were run in Python versions 2.7 and 3.6. 







4.1 Database calculations 





 values in 
the range of 0.05 − 69.5 𝐺𝑦, however, as further datapoints were excluded, this range 




, both before and after the new restrictions. The calculated 𝑅𝐵𝐸𝑚𝑖𝑛 range of 
0 − 3.4 was not affected by the exclusion either. The 𝑅𝐵𝐸𝑚𝑎𝑥 values were originally 
in the range 0 − 80, but following the restrictions a final 𝑅𝐵𝐸𝑚𝑎𝑥 range of 0 − 7.2 was 
obtained,  due to the now excluded experiments. 
38 of the total 98 experiments in the database have an 𝑅𝐵𝐸𝑚𝑖𝑛 value higher than its 
𝑅𝐵𝐸𝑚𝑎𝑥 value, where one was the excluded Baggio et al 2002 [40] experiment, 
resulting in 37 out of the 94 experiments in the restricted database having 𝑅𝐵𝐸𝑚𝑖𝑛 >
𝑅𝐵𝐸𝑚𝑎𝑥. These experiments included all 12 experiments from Patel et al 2017 [56], 
13 experiments from Guan et al 2015 [22], two from Bird et al 1980 [44], two from 
Green et al 2002 [50] and one experiment each from  Fuhrman Conti et al 1988 [48], 
Wainson et al 1972 [64], Sgura et al 2000 [62], Jeynes et al 2013 [54], Slonina et al 
2014 [63], Perris et al 1986 [57], Belli et al 2000 [42] and Folkard et al 1989 [47]. 








Table 2: The data used in this thesis listed in the order of ascending cluster membership. 




















𝑅𝐵𝐸𝑚𝑖𝑛 𝑅𝐵𝐸𝑚𝑎𝑥 Reference Cluster 
membership 
       
60-Co 1.790 0.420 1.072 2.925 Green et al 2002 1 
225kVp 1.833 0.392 1.033 1.273 Chaudhary et al 
2014 
1 
225kVp 1.833 3.302 1.041 1.545 Chaudhary et al 
2014 
1 
225kVp 1.833 6.282 1.088 2.000 Chaudhary et al 
2014 
1 
225kVp 1.833 11.182 0.866 4.000 Chaudhary et al 
2014 
1 
225kVp 1,833 17.282 0.365 7.000 Chaudhary et al 
2014 
1 
60-Co 1.889 0.420 0.923 2.373 Green et al 2001 1 
240kVp 2.708 9.408 0.901 2.462 Folkard et al 1996 1 
137-Cs 3.892 0.390 0.658 0.757 Wainson et al 
1972 
1 
60-Co 3.957 0.420 0.824 1.111 Green et al 2002 1 
250kVp 4.040 8.555 2.332 1.975 Bird et al 1980 1 
6 MV 4.081 1.980 0.959 1.464 Howard et al 2017 1 
6 MV 4.081 3.560 1.151 1.609 Howard et al 2017 1 
6 MV 4081 4.550 1.174 2.245 Howard et al 2017 1 
6 MV 4.081 7.540 1.078 3.106 Howard et al 2017 1 
6 MV 4.081 1.190 0.959 1.470 Howard et al 2017 1 
6 MV 4.081 2.460 0.986 1.517 Howard et al 2017 1 
6 MV 4.081 4.390 1.115 1.914 Howard et al 2017 1 
6 MV 4.081 7.490 1.315 2.026 Howard et al 2017 1 
250kVp 5.000 8.555 3.152 1.493 Bird et al 1980 1 
60-Co 5.105 0.420 1.024 0.839 Green et al 2002 1 
137-Cs 5.156 0.390 0.919 0.810 Wainson et al 
1972 
1 
60-Co 5.405 0.420 1.000 0.890 Green et al 2002 1 
120kVp 5.813 5.243 1.132 1.188 Moertel et al 2004 1 
120kVp 6.387 5.243 1.231 2.545 Moertel et al 2004 1 
250kVp 11.333 16.325 1.528 3.412 Prise et al 1990 1 
6MV 12.379 8.100 0.983 1.134 Slonina et al 2014 1 
6MV 13.063 8.100 1.137 1.005 Slonina et al 2014 1 
6MV 16.805 8.100 0.988 1.241 Slonina et al 2014 1 
60-Co 23.333 5.800 1.958 1.500 Perris et al 1986 1 
       
137-Cs 2.286 9.600 0.474 6.196 Hei et al 1988a 2 
225kVp 8.710 6.282 0.813 2.389 Chaudhary et al 
2014 
2 



















𝑅𝐵𝐸𝑚𝑖𝑛 𝑅𝐵𝐸𝑚𝑎𝑥 Reference Cluster 
membership 
       
225kVp 8.710 17.282 1.092 3.463 Chaudhary et al 
2014 
2 
225kVp 8.710 3.302 0.992 1.889 Chaudhary et al 
2014 
2 
225kVp 8.710 0.392 1.385 1.389 Chaudhary et al 
2014 
2 
60-Co 18.387 19.700 0.000 1.526 Belli et al 2000 2 
250 kVp 18.444 9.325 0.000 2.482 Wera et al 2013 2 
       
137-Cs 1.220 17.300 1.906 6.560 Guan et al 2015 3 
137-Cs 1.220 14.800 1.522 3.600 Guan et al 2015 3 
137-Cs 1.220 10.400 1.148 2.380 Guan et al 2015 3 
240 kVp 2.708 10.208 0.979 1.854 Schettino et al 
2001 
3 
240kVp 2.708 17.108 0.764 3.462 Folkard et al 1996 3 
200 kVp 2.804 19.236 0.967 3.636 Belli et al 1998 3 
200 kVp 2.804 10.236 0.885 2.884 Belli et al 1998 3 
200 kVp 2.804 6.936 0.722 2.240 Belli et al 1998 3 
60Co 3.083 7.700 0.000 1.270 baggio et al 2002 3 
137-Cs 3.494 10.400 1.362 1.097 Guan et al 2015 3 
137-Cs 3.514 15.200 1.162 2.462 Schuff et al 2002 3 
250kVp 4.074 16.325 1.291 3.182 Prise et al 1990 3 
250kVp 4.074 16.325 1.700 1.182 Folkard et al 1989 3 
250 kVp 4.390 9.325 0.855 1.722 Hei et al 1988b 3 
300kVp 5.217 16.482 1.707 1.000 Jeynes et al 2013 3 
60-Co 7.647 19.800 0.485 1.769 Belli et al 2000 3 
60-Co 7.647 7.700 0.804 1.154 Belli et al 2000 3 
60-Co 7.667 7.700 0.876 0.843 Sgura et al 2000 3 
60-Co 15.000 19.700 1.541 1.792 Bettega et al 1989 3 
60-Co 15.000 11.000 1.090 1.958 Bettega et al 1989 3 
60-Co 18.387 7.700 1.723 0.719 Belli et al 2000 3 
60-Co 23.333 12.100 0.000 3.071 Perris et al 1986 3 
       
137-Cs 1.220 0.800 0.698 2.720 Guan et al 2015 4 
137-Cs 1.220 0.500 0.826 1.540 Guan et al 2015 4 
137-Cs 1.220 1.500 0.870 1.880 Guan et al 2015 4 
137-Cs 1.220 2.600 0.897 2.220 Guan et al 2015 4 
137-Cs 1.220 1.400 0.963 1.180 Guan et al 2015 4 
137-Cs 1.220 1.900 0.883 1.920 Guan et al 2015 4 
137-Cs 1.220 4.700 1.126 0.680 Guan et al 2015 4 
137-Cs 1.220 1.200 0.812 1.340 Guan et al 2015 4 
137-Cs 3.494 4.700 1.384 0.403 Guan et al 2015 4 
137-Cs 3.494 2.600 1.227 0.710 Guan et al 2015 4 

















𝑅𝐵𝐸𝑚𝑖𝑛 𝑅𝐵𝐸𝑚𝑎𝑥 Reference Cluster 
membership 
       
137-Cs 3.494 1.400 1.271 0.517 Guan et al 2015 4 
137-Cs 3.494 1.200 1.271 0.521 Guan et al 2015 4 
137-Cs 3.494 0.500 1.081 0.924 Guan et al 2015 4 
137-Cs 3.494 1.900 1.326 0.472 Guan et al 2015 4 
137-Cs 3.494 0.600 1.252 0.586 Patel et al 2017 4 
137-Cs 3.494 0.800 1.162 0.779 Guan et al 2015 4 
137-Cs 3.494 9.200 1.770 0.414 Patel et al 2017 4 
137-Cs 3.494 6.800 1.513 0.759 Patel et al 2017 4 
137-Cs 3.494 3.900 1.770 0.000 Patel et al 2017 4 
137-Cs 3.494 2.100 1.431 0.379 Patel et al 2017 4 
137-Cs 3.494 5.700 1.736 0.000 Patel et al 2017 4 
137Cs 3.514 2.700 0.735 2.385 Schuff et al 2002 4 
60-Co 28.467 1.850 1.390 0.852 Fuhrman Conti et 
al 1988 
4 
       
137-Cs 1.220 18.600 2.576 7.200 Guan et al 2015 5 
137-Cs 3.494 18.600 3.394 3.045 Guan et al 2015 5 
137-Cs 3.494 17.300 2.824 2.055 Guan et al 2015 5 
137-Cs 3.494 13.200 2.140 0.586 Patel et al 2017 5 
137-Cs 3.494 19.100 3.026 1.241 Patel et al 2017 5 
137-Cs 3.494 16.100 2.430 0.621 Patel et al 2017 5 
137-Cs 3.494 14.800 2.328 0.414 Patel et al 2017 5 
137-Cs 3.494 17.700 2.733 0.793 Patel et al 2017 5 
137-Cs 3.494 11.700 1.964 0.345 Patel et al 2017 5 
137-Cs 3.494 14.800 2.027 1.538 Guan et al 2015 5 
       
60-Co 17.100 1.040 1.517 1.749 Petrovic et al 2006 Excluded 
60-Co 69.500 7.700 1.732 0.230 Baggio et al 2002 Excluded 
137-Cs 0.051 2.290 0.751 35.000 Schuff et al 2002 Excluded 
137-Cs 0.051 13.600 0.877 80.000 Schuff et al 2002 Excluded 
       
4.2 Cluster Analysis 
The lowest AIC-value obtained was at five clusters as seen in Figure 8, and this number 
of clusters also gave a satisfactory Silhouette measure of 0.46. The BIC value, however, 
was lowest at three clusters with almost no change between two and four clusters, 
implying a difference of opinion between the information loss models. The silhouette 
score did not change much when the number of clusters was altered, however, they 
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appear to improve slightly for a higher number of clusters. Too many clusters, however, 
increased the information loss. Because of this, a fixed value of five clusters was chosen 
for further analysis. This was also the number of clusters chosen by SPSS if a fixed 
value was not specified. The Silhouette measure of 0.46, is according to SPSS a “fair” 
clustering, and close to 0.5 being classified as “good”. 
 
Figure 8: The loss of information as a function of the number of clusters, calculated using 
Bayesian Information Criterion (Blue) and Akaike Information Criterion (Red) respectively. 
The Silhouette scores for 2-15 clusters are also depicted as Green bars. 
The highest weighted variable when deciding the cluster memberships for each 
experiment, according to the predictor importance, was the 𝛽 value closely followed 
by the 𝐷𝑚𝑖𝑛 value at 0.945. Slightly lower weighted was the 𝛼 value at 0.692. And 
lowest weighted of the input variables was the 𝐿𝐸𝑇𝑑 values, weighted at 0.661 relative 
to 𝛽 according to equation (21). This implies that the 𝛽 and 𝐷𝑚𝑖𝑛 variables explain the 
separation of the clusters better than the 𝐿𝐸𝑇𝑑  and 𝛼 values can. This can be seen in 




Figure 9: Predictor Importance for each of the input variables, for a 5-cluster model. 
The distribution, average values, and standard deviation of each input variable, and for 
each cluster, are displayed in Figure 10. The same values are displayed for the 
evaluation fields in Figure 11. The average values and standard deviations are listed in 
Table 3. The clusters are plotted from bottom to top sorted by increasing average 𝐿𝐸𝑇𝑑 
value within each of the subplots in Figure 10 and Figure 11, meaning that in each 
subplot the data is sorted from bottom to top in the following order: Cluster 4 (Green), 
Cluster 1 (Red), Cluster 2 (Blue), Cluster 3 (Purple) and Cluster 5 (Cyan). The subplots 
themselves are displayed in order of decreasing Predictor Importance from top to 
bottom. 
The number of experiments in each of the five clusters were unevenly distributed into 
three large clusters (number of datapoints): Clusters 1 (30), 3 (22) and 4 (24) and two 





Table 3: Mean value of each variable considered in the analysis with accompanying standard 
deviation for each model and for the entire dataset (All clusters), rounded to two decimals. 
Mean and Standard deviation 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 All 
Clusters 
𝜷[𝑮𝒚−𝟐] 0.05 ± 0.04 0.05 ± 0.04 0.05 ± 0.04 0.11 ± 0.08 0.53 ± 0.22 0.12 ± 0.17 
𝑫𝒎𝒊𝒏[𝑮𝒚] 1.26 ± 0.36 0.28 ± 0.14 0.57 ± 0.26 0.35 ± 0.15 0.33 ± 0.18 0.68 ± 0.48 




] 5.26 ± 4.58 9.63 ± 6.53 
12.89
± 4.34 
2.59 ± 2.20 
16.19
± 2.50 






[𝑮𝒚] 5.66 ± 4.95 10.33
± 5.46 
6.36 ± 6.07 3.78 ± 5.37 3.27 ± 0.72 5.49 ± 5.38 
𝑹𝑩𝑬𝒎𝒂𝒙 1.96 ± 1.25 2.81 ± 1.55 2.27 ± 1.33 0.99 ± 0.74 1.78 ± 2.08 1.84 ± 1.39 
𝑹𝑩𝑬𝒎𝒊𝒏 1.16 ± 0.51 0.74 ± 0.52 1.07 ± 0.51 1.19 ± 0.32 2.54 ± 0.46 1.26 ± 0.65 
 
From Figure 10 it can be seen that for 𝛼, 𝛽 and 𝐷𝑚𝑖𝑛, a single cluster contains the 
distinctly highest values for each of the aforementioned variables, distinctly separated 
from the other clusters. 𝐿𝐸𝑇𝑑 however, has a smoother transition from each cluster to 
the next where the average 𝐿𝐸𝑇𝑑 increases approximately linearly from one cluster to 
the next (Figure 10). The standard deviation for the 𝐿𝐸𝑇𝑑 is also significantly 
overlapping for the clusters with the closest average 𝐿𝐸𝑇𝑑 value, however, for the rest 





Figure 10: Cluster comparison of input variables. All datapoints in each cluster are shown as 
dots for each input variable, with mean value marked as a circle with error bars of ± one 






Figure 11: Cluster comparison of evaluation fields. All datapoints in each cluster are shown 
as dots for each input variable, with mean value marked as a circle with error-bars of ± one 
standard deviation of the mean. 
For the evaluation fields in Figure 11, it can be seen that the only cluster with a standard 
deviation not overlapping with another cluster is Cluster 5 for the 𝑅𝐵𝐸𝑚𝑖𝑛. This can be 
explained by the similar form of the 𝛽 values as seen in Figure 10, and the definition 
of 𝑅𝐵𝐸𝑚𝑖𝑛 as given by equation (10). 𝑅𝐵𝐸𝑚𝑎𝑥 has the highest average values in Cluster 
2, however, the distribution is not as extreme as the 𝑅𝐵𝐸𝑚𝑖𝑛 distribution compared to 
the other clusters, even though the 𝛼 distribution for Cluster 2 is similar to the 𝛽 
distribution for Cluster 5.  





 have a similar shape where they seem to 






 have the same shape, also indicates that 𝑅𝐵𝐸𝑚𝑎𝑥 should be 
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. The 𝑅𝐵𝐸𝑚𝑖𝑛 seem to have the opposite trend where 
the average 𝑅𝐵𝐸𝑚𝑖𝑛 value decreases for the low 𝐿𝐸𝑇𝑑 clusters and starts increasing for 
high 𝐿𝐸𝑇𝑑 clusters. 
Otherwise, overlapping standard deviations in the evaluation fields for all variables are 
observed to a high degree, where only Cluster 5 has no overlap with the other clusters 





, clusters 5 and 2 avoid overlapping standard deviations. 
For 𝑅𝐵𝐸𝑚𝑎𝑥 every single cluster is observed to have an overlapping standard deviation 
with the other clusters. 
Seven of the experiments with higher 𝑅𝐵𝐸𝑚𝑖𝑛than 𝑅𝐵𝐸𝑚𝑎𝑥 are found in Cluster 1, 
Cluster 2 have none, five are found in Cluster 3, 16 in Cluster 4 and nine in Cluster 5. 
This is also reflected in Figure 11, where it is clear that Clusters 4 and 5 have a higher 
average 𝑅𝐵𝐸𝑚𝑖𝑛 value than 𝑅𝐵𝐸𝑚𝑎𝑥. This is also supported by the 𝛽 distribution seen 
in Figure 10, showing a higher average 𝛽 value for Cluster 4 and, particularly, Cluster 
5, compared to the other clusters, as well as noticeably low 𝛼 values, especially for 
Cluster 4. This together with the 𝛼 and 𝛽 dependencies of equations (9) and (10) 
explain the distribution of experiments with higher 𝑅𝐵𝐸𝑚𝑖𝑛 than 𝑅𝐵𝐸𝑚𝑎𝑥. The exact 
opposite is observed for Cluster 2, which has no 𝑅𝐵𝐸𝑚𝑖𝑛 values higher than 𝑅𝐵𝐸𝑚𝑎𝑥. 
The 𝛽 values for this cluster are among the lowest whereas the 𝛼 values are clearly the 
highest. 
Results from the cluster analysis, including outliers, can be found in Appendix B. The 
biggest differences between the two cluster analysis is that for the 98 experiment 
database, a singleton cluster was created. This cluster included only the Petrovic et al 
experiment, with a 𝐷𝑚𝑖𝑛 value of 8.015 Gy. A preferable predictor importance was also 
observed in this cluster analysis. Excluding the datapoints was still considered to be 




4.3 Model Comparison 
The model comparisons are ordered according to the percentage of experiments in their 
database that were also included in the database used in this thesis. The percentage is 
shown in parenthesis in each title. The following models had five or fewer common 
datapoints with our database: Belli et al, Jones et al, Carabe et al, Chen and Ahmad et 
al, and Tilly et al. Of these, only the Tilly et al model was analyzed further because of 
its high percentage of common datapoints. All model equations for the models analyzed 
further can be found in Appendix C. 
 
4.3.1 McNamara [81] (15%) 
The database used as a basis for this model was the database found in Paganetti et al 
[26], which was also one of three major sources for the database used in this thesis. 
McNamara had the restriction of 𝐿𝐸𝑇𝑑 < 20
𝑘𝑒𝑉
𝜇𝑚
, which is similar to our restriction, 





< 30 𝐺𝑦. The main difference 
in restrictions between the two databases is our restriction of only including 
monoenergetic experiments. This leads to only 44 shared experiments between the two 
databases, out of the total 285 experiments in the McNamara database. 17 of the 
datapoints are assigned to Cluster 1, 8 datapoints in Cluster 2, 17 points in Cluster 3 
and 2 points in Cluster 4. Only Cluster 5 is not represented in McNamara’s database. 
The McNamara model predicts an increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑, as well 





. The model also seems to predict a slight decrease in 










4.3.2 Mairani [82] (42%) 
The Mairani database is based on the database from the upcoming Wedenberg model, 
with an additional seven datapoints. None of these seven additional datapoints were 
included in our database, meaning that the distribution of data in clusters for the 
Mairani model is identical to the distribution for the Wedenberg model. This database 





= ∞.  There was a total of 13 common datapoints, one point 
from Cluster 1, one point in Cluster 2 and 11 points from Cluster 3. Similar to earlier 
models, this model predicts an increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑, and a 
decreasing 𝑅𝐵𝐸𝑚𝑖𝑛 with an increasing 𝐿𝐸𝑇𝑑. The model considers the biological effect 
of the primary protons, as well as secondary protons, deuterons, tritons, and helium 
fragments. 
 
4.3.3 Wilkens and Oelfke [28] (42%) 
The Wilkens and Oelfke model consists of 19 datapoints where 7 of them correspond 
to datapoints in Cluster 1, as well as one datapoint belonging to Cluster 3, adding up to 
a total of 8 common datapoints. The remaining 11 points were not included in our 
database, due to our restrictions of only including monoenergetic experiments and 
𝐿𝐸𝑇𝑑 values lower than 20
𝑘𝑒𝑉
𝜇𝑚
. In this model it is also suggested that 𝛼 increases with 
an increasing 𝐿𝐸𝑇, however, only 𝛼 values up to 0.8 𝐺𝑦−1 were included in the model. 
The model also suggests that 𝛽 is kept stable around 𝛽 = 0.0298𝐺𝑦−2, however, the 
spread within the experimental data increases with increasing 𝐿𝐸𝑇𝑑. Furthermore, the 









4.3.4 Peeler [83] (50%) 
The Peeler model consists of 48 datapoints, 24 from Guan and Bronk et al [22] and the 
remaining 24 from a refit of the same data. The original data from Guan and Bronk et 
al [22] was included in this database and distributed with 4 points in Cluster 3, 16 
points in Cluster 4 and the remaining 4 points in Cluster 5. Like most other models this 
model predicts an increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑, however, this model also 
predicts an increasing 𝑅𝐵𝐸𝑚𝑖𝑛 with increasing 𝐿𝐸𝑇𝑑. 
 
4.3.5 Wedenberg [79] (54%) 
The Wedenberg model included 24 datapoints, as mentioned in the Mairani comparison 





= ∞. No data from our database 
shared this quality. From the remaining 19 points, one corresponds to data in Cluster 
1, one in Cluster 2 and 11 datapoints can be found in Cluster 5, adding up to a total of 
13 common datapoints. The remaining six datapoints were not included in our 












4.3.6 Rørvik [25] (71%) 
The Rørvik database was one of three used as basis for the database gathered in this 
thesis, however, with a couple of differences in the restrictions set. Rørvik had 








< 25 𝐺𝑦, whereas our database restricted 𝐿𝐸𝑇𝑑 
to 20 𝑘𝑒𝑉/𝜇𝑚. Of the 85 datapoints in this database, 60 of them were included in our 
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database. 11 in Cluster 1, 7 in Cluster 2, 21 in Cluster 3, 17 in Cluster 4 and 4 in Cluster 
5. 
Rørvik developed two models to fit the data, one weighted and one unweighted linear 
model. The weighted model depends on a Biological Weighting Function, but for 
comparison with the linear models created for each cluster, only the unweighted linear 
model is of interest. 
 
4.3.7 Tilly [67] (81%) 





 was the differentiator. One model 





 ~2 𝐺𝑦. Of these datapoints, one can be found in 
Cluster 1 and 4 are found in Cluster 3. The remaining 2 datapoints were not included 
in our database. This model predicts, similarly to many other models, an increasing 
𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑 up to about 𝐿𝐸𝑇𝑑 = 30
𝑘𝑒𝑉
𝜇𝑚
 with an experimental 






~10 𝐺𝑦. All the aforementioned datapoints can be found in Cluster 3. This model 
also predicts a rise in 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑, however, with a significantly 






4.4 RBE modelling 
The curve fit tool from MATLAB gave us fitting variables for the 𝑅𝐵𝐸𝑚𝑖𝑛 equations 










. For the 𝑅𝐵𝐸𝑚𝑎𝑥 curve fit we got 










, showing a 
significantly greater spread. 
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The fitting variable, the R-squared value, and the 95% confidence interval for each 
model are listed for the 𝑅𝐵𝐸𝑚𝑖𝑛 curve fit in Table 4, and the same are listed for the 
𝑅𝐵𝐸𝑚𝑎𝑥 curve fit in Table 5.  
A positive fitting variable predicts an increasing 𝑅𝐵𝐸 with increasing 𝐿𝐸𝑇𝑑 for both 





 value for the 𝑅𝐵𝐸𝑚𝑎𝑥. This can be seen in 
Figure 12 and Figure 13. 
Table 4: Fitting variable for 𝑅𝐵𝐸𝑚𝑖𝑛, with accompanying goodness of fit statistic R-squared, 
and 95% confidence interval for each of the models created with the curve fit tool in MATLAB. 








R-squared 95% confidence interval 
Cluster 1 0.027 0.030 [−0.001, 0.054] 
Cluster 2 −0.031 0.223 [−0.065, 0.003] 
Cluster 3 0.008 0.034 [−0.008, 0.025] 
Cluster 4 0.082 0.405 [0.052, 0.113] 
Cluster 5 0.097 0.633 [0.085, 0.109] 









Table 5: Fitting variable for 𝑅𝐵𝐸𝑚𝑎𝑥, with accompanying goodness of fit statistic R-squared, 
and 95% confidence interval for each of the models created with the curve fit tool in MATLAB. 








R-squared 95% confidence interval 
Cluster 1 0.583 0.710 [0.479, 0.687] 
Cluster 2 1.271 0.870 [1.008, 1.534] 
Cluster 3 0.303 0.615 [0.235, 0.371] 
Cluster 4 −0.006 −5.488 ∗ 10−5 [−0.237, 0.225] 
Cluster 5 0.248 0.512 [0.088, 0.408] 
All clusters 0.331 0.426 [0.273, 0.389] 
 
The fitted curves for 𝑅𝐵𝐸𝑚𝑖𝑛 are shown in Figure 12, and the fitted planes for 𝑅𝐵𝐸𝑚𝑎𝑥 
are shown in Figure 13. 
 
Figure 12: Each line depicts the 𝑅𝐵𝐸𝑚𝑖𝑛 as a function 𝐿𝐸𝑇𝑑 by fitting the experimental data in 
each cluster to equation (22). The yellow line represents the model where all experimental 
data in all clusters was fitted to the same equation. 
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Clusters  4 and 5 predict a slope for the 𝑅𝐵𝐸𝑚𝑖𝑛 of about 0.1 with increasing 𝐿𝐸𝑇𝑑, as 
seen by their fitting variables, whereas Clusters 1 and 3 predict a significantly 
shallower slope. Finally, Cluster 2 is the only Cluster to predict a decreasing 𝑅𝐵𝐸𝑚𝑖𝑛 
to 𝐿𝐸𝑇𝑑, with a slope of −0.03. As expected, the model considering all the data is 
located close to the centre of the other models. 
For the linear 𝑅𝐵𝐸𝑚𝑖𝑛 fits, we observe a wide spread in the experimental data 
represented in the low R-squared values in Table 4. The Cluster 1 and Cluster 3 models 
have the lowest R-squared values of 0.034 or lower, whereas the Cluster 4 and Cluster 
5 models present fewer variations with higher R-squared values of 0.40 and 0.63, 
respectively. The Cluster 2 model, and the All clusters model present R-squared values 
of 0.22 and 0.12, respectively, representing a bad fit. They are, however, not as bad as 










 by fitting the 
experimental data from each cluster to equation (23). The yellow plane represents the 
model where all experimental data in all clusters was fitted to the same equation. 
From Figure 13 it is clear that most models predict an increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with 





 values. Only the model 
from Cluster 4 predicts a decreasing 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇𝑑, and the slope gets 





 values in this model as well, albeit with a negative slope. 
Clusters 1 and 2 predict the steepest slope with regards to 𝐿𝐸𝑇𝑑. 
The overall “goodness of fit” within the 𝑅𝐵𝐸𝑚𝑎𝑥 fit is significantly better than within 
the 𝑅𝐵𝐸𝑚𝑖𝑛 fit. This is seen from the high R-squared values as presented in Table 5. 
The obvious exception is the Cluster 4 model with a negative R-squared value. This is, 
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according to MATLAB only possible “if the model does not contain a constant term 
and the fit is worse than just fitting the mean”. The rest of the models have R-squared 
values between 0.426 and 0.870, where the Cluster 2 model represents the best fit to 
its experimental data, and the All clusters model represents the worst fit, if the Cluster 
4 model is disregarded. The fit of the best and worst fitted planes to its models 
experimental data (Cluster 2 and Cluster 4, respectively) are visualized in Figure 14. 
 
Figure 14: Fitted plane representing the 𝑅𝐵𝐸𝑚𝑎𝑥 for Cluster 2 and Cluster 4 plotted together 
with the experimental data from the same clusters to illustrate the “goodness of fit”. A slightly 
different shade, of blue and green respectively, was utilized in this plot to make the 
experimental datapoints easier to see. The z-axis for Cluster 4 in the plot is larger than the 










The model equations for each of the models are written explicitly as follows: 
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4.5 FLUKA simulation and dose calculatons 
The two-dimensional dose distribution, calculated based on the FLUKA MC 
simulations in Chapter 3.5, is shown in Figure 16. It depicts the distribution for all the 
relevant models in a slice 1 mm from the center of the phantom, as the voxel file 
definitions made this the closest slice to the center of the PTV. A one-dimensional 
depth dose distribution for the same models is also shown in Figure 15. These figures 
show that only the 𝑅𝐵𝐸 = 1.1 model predicts a reasonably homogeneous dose 
distribution, which is explained by the model not taking the 𝐿𝐸𝑇𝑑 into account. The 
rest of the models predict a higher dose in the distal edge of the SOBP, where the 
models for Cluster 1 and Cluster 2 clearly predict the highest doses. This is explained 
by the high fitting variables for the 𝑅𝐵𝐸𝑚𝑎𝑥 model equations (25) and (27), for these 
models in particular. The 𝐿𝐸𝑇𝑑 distribution, obtained from the FLUKA simulation 
shows an increasing 𝐿𝐸𝑇𝑑 in the distal edge of the SOBP and is given in Appendix E. 
 
Figure 15: Depth dose distribution of the simulated proton beam calculated for RBE of 1.1, 
Unweighted Rørvik model (Chapter 4.3.6) ), models for each clusters and model based on all 




Figure 16: Dose distribution based on the FLUKA Monte Carlo simulation calculated with RBE 
of 1.1, Unweighted Rørvik model [25] equations (Chapter 4.3.6), model equations for all 
clusters and model equations for each separate cluster (Chapter 4.4). The PTV is illustrated 
as a red square. 
The DVHs from the MC simulation are shown in Figure 17. It is again clear that the 
models for Cluster 1 and Cluster 2 predict a distinctly higher dose to the PTV, whereas 
the 𝑅𝐵𝐸 = 1.1 model gives the most homogenous and lowest dose. The maximum and 
minimum doses, as well as the dose absorbed by at least 50% of the PTV is listed for 
each model in Table 6. It is shown here that voxels within the PTV receive absorbed 
doses in the range 1.6 𝐺𝑦(𝑅𝐵𝐸) to 3.5 𝐺𝑦(𝑅𝐵𝐸). From Figure 15, Figure 16, Figure 
17, and Table 6 we observe a striking resemblance between the Cluster 5 model and 





Table 6: DVH values of 𝐷(0%) or max dose, 𝐷(50%) measuring the those absorbed by 
50% of the PTV, and 𝐷(100%) or minimum dose for the PTV. 
Model 𝑫𝒎𝒂𝒙[𝑮𝒚(𝑹𝑩𝑬)] 𝑫𝟓𝟎% [𝑮𝒚(𝑹𝑩𝑬)] 𝑫𝒎𝒊𝒏 [𝑮𝒚(𝑹𝑩𝑬)] 
𝑅𝐵𝐸1.1 2.10 1.97 1.60 
Unweighted 
Rørvik 
2.80 2.31 1.70 
All Clusters 2.60 2.18 1.70 
Cluster 1 3.30 2.56 1.90 
Cluster 2 3.50 2.67 2.00 
Cluster 3 2.40 2.08 1.60 
Cluster 4 2.40 2.07 1.60 
Cluster 5 2.90 2.31 1.70 
 
Figure 17: The DVH of biological dose absorbed by the PTV for all models. 
The RBE distributions are shown in Figure 18Figure 18. In this plot, voxels with a dose 
value lower than 0.1 𝐺𝑦(𝑅𝐵𝐸) are set transparent. The RBE distribution, similarly to 
the dose distribution, seem to be highest in the distal edge of the field, where again the 
Cluster 1 and Cluster 2 models predict the highest RBE of the cluster models. The 





Figure 18: Two-dimensional RBE distribution from the FLUKA simulation recalculated from 
the model equations created in this thesis with the unweighted Rørvik model for comparison. 





From our cluster analysis, five clusters (sub-databases) were created. For three of the 
input variables used in the analysis, 𝛼, 𝛽, and 𝐷𝑚𝑖𝑛, one cluster distinguished itself 
from the others within each of the three variables, showing a clearly higher average 
value from the other clusters. These clusters were Cluster 2 for the 𝛼 values, Cluster 5 
for the 𝛽 values, and Cluster 1 for the 𝐷𝑚𝑖𝑛 values, respectively, as seen in Figure 10. 
Common RBE-modelling relationships for 𝑅𝐵𝐸𝑚𝑖𝑛 and 𝑅𝐵𝐸𝑚𝑎𝑥 were investigated for 
each cluster by fitting them to equations (22) and (23). The fitting variables for the 
𝑅𝐵𝐸𝑚𝑖𝑛, representing the slope as a function of 𝐿𝐸𝑇𝑑, had only limited variation 










, where only Cluster 2 predicts a 



















Most models reviewed in this thesis assumed a 𝑅𝐵𝐸𝑚𝑖𝑛 = 1. For 𝑅𝐵𝐸𝑚𝑎𝑥, however, 
we can see that most models found in Appendix C have a fitting variable closest to the 
“All clusters” model emulated in this thesis. The McNamara, Mairani, and Wedenberg 
models all have a 𝑅𝐵𝐸𝑚𝑎𝑥 fitting variable close to the one found for the All clusters 





~10𝐺𝑦, also depict 
a fitting variable close to the Clulster 1 fitting variable. This is found by comparing the 
values in Table 5 with the equations found in Appendix C. Only Cluster 4 predicts a 
negative slope for the 𝑅𝐵𝐸𝑚𝑎𝑥. 𝑅𝐵𝐸𝑚𝑖𝑛, generally, displays a greater variation in the 
relevant experimental data as reflected by the R-squared values in Table 4.  
The clusters, and their model relationship, were also explored for recalculation of the 
biological dose and RBE distributions from a simulated proton irradiation. The high 𝛼, 
and high 𝐷𝑚𝑖𝑛 databases of the Cluster 1 and Cluster 2 models resulted in the distinctly 
highest doses to the distal edge of the simulated SOBP, and the clearly highest DVH 




The fact that nearly 38% of the experiments in the final database resulted in a higher 
𝑅𝐵𝐸𝑚𝑖𝑛 value than 𝑅𝐵𝐸𝑚𝑎𝑥 value is very surprising and contradicts the outcome 
expected from the theory. This can possibly be explained by the IndRep and LQC 
models in the low and high dose ranges, respectively, as these models propose a 
correction of the inaccuracies of the LQ model in these dose ranges.  
Many of the experiments included in our database are quite recent, such as the ones 
from Howard et al and Patel et al, which were both published in 2017. Comparing our 
database to the databases used in earlier models, such as Wilkens and Oelfke et al, and 
Tilly et al, from 2004 and 2005, respectively, is not completely fair as these models 
would not have access to the newer data. However, there was still large amounts of 
experimental data available when these models were published. 
The restriction of 𝐿𝐸𝑇𝑑 < 20
𝑘𝑒𝑉
𝜇𝑚
 is reasonable as this is the range used clinically. The 
inclusion of the lowest dose value from each experiment was thought to reflect the 
preciseness of the 𝑅𝐵𝐸𝑚𝑖𝑛, as this is defined in the low dose region. Earlier studies 
have shown that 𝐷𝑚𝑖𝑛 affect the fit of 𝑅𝐵𝐸𝑚𝑖𝑛 [8]. However, by the same logic, the 
maximum dose value from each experiment could, therefore, also be included, as this 
is the region where the 𝑅𝐵𝐸𝑚𝑎𝑥 is defined. However, as the max dose in most 
experiments was well above the typical fraction dose of 2 Gy, the impact of the 
maximum dose may be less than that of 𝐷𝑚𝑖𝑛.  
5.1.1 Quality of the cluster analysis 
The Silhouette score did not vary much, and the AIC and BIC models did not agree on 
the optimal number of clusters. This indicates that the clustering might not be optimal, 
and a different number of clusters could be argumented for. This is also reflected in the 
sub-optimal Predictor Importance. A model with more even predictor importance 
would be preferable, such as the one presented in Appendix B. The drop in Predictor 
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Importance, especially in the variables 𝛼 and 𝐿𝐸𝑇𝑑, means that the clusters can be 
misrepresented, especially regarding 𝑅𝐵𝐸𝑚𝑎𝑥, as these variables are most commonly 
used when deriving 𝑅𝐵𝐸𝑚𝑎𝑥, whereas 𝛽 and 𝐷𝑚𝑖𝑛 is commonly not considered as RBE 
parameters. These quality indicators were considered decent and the cluster analysis 
was kept, however, a model with a different number of clusters or even another 






 as an input variable in the cluster analysis could also be questioned. 
Even if it could be considered a “swamping variable”, meaning a variable that hijacks 
the clustering, it does present important information on modelling with regards to the 
tissue, and how it might react to radiation. As mentioned earlier, the maximum dose 
included in each experiment could also be included in the database, and also as an input 
variable in the cluster analysis, by the same logic as for the minimum dose. The number 
of dose – survival fraction datapoints in each experiment may also affect the LQ fit and 
thereby, the 𝛼 and 𝛽 parameters. This could also be introduced as a variable included 
in the cluster analysis. 
5.1.2 Clustering results 





, with the  





 values increasing from cluster to cluster with increasing 
average 𝐿𝐸𝑇𝑑 values, for the lowest 𝐿𝐸𝑇𝑑 clusters (Clusters 4, 1, and 2, ordered by 
increasing 𝐿𝐸𝑇𝑑). For the high 𝐿𝐸𝑇𝑑 clusters (Clusters 2, 3, and 5, ordered by 





 with increasing 𝐿𝐸𝑇𝑑. 









with a following drop for both variables. This can be seen in Figure 10 and Figure 11. 
A similar trend is reported in several of the models investigated in chapter 3.3, such as 
Tilly et al [67] and Wilkens and Oelfke [28], however, in these models a decrease in 
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𝑅𝐵𝐸𝑚𝑎𝑥 does not occur until 𝐿𝐸𝑇𝑑 values of about 30 𝑘𝑒𝑉/𝜇𝑚, whereas our database 
had a maximum 𝐿𝐸𝑇𝑑 value of 20 𝑘𝑒𝑉/𝜇𝑚. The high standard deviations in both 𝐿𝐸𝑇𝑑 
and 𝑅𝐵𝐸𝑚𝑎𝑥 in our study do, however, leave this dependency weak. 






. The average 𝑅𝐵𝐸𝑚𝑖𝑛 value decreases with increasing 𝐿𝐸𝑇𝑑 for the low 𝐿𝐸𝑇𝑑 
clusters. After this, an increase in 𝑅𝐵𝐸𝑚𝑖𝑛 is seen from Cluster 2 to Cluster 3 and on to 
Cluster 5. A decrease in 𝑅𝐵𝐸𝑚𝑖𝑛 with increasing 𝐿𝐸𝑇𝑑 is also reported in the Mairani 
et al [82] and McNamara et al [81] models among others, however a following 
increasing 𝑅𝐵𝐸𝑚𝑖𝑛 for higher 𝐿𝐸𝑇𝑑 values have not been found in any literature studied 
for this thesis. In this aspect, most RBE models assume a constant 𝑅𝐵𝐸𝑚𝑖𝑛 equal to 
one [31]. 
The distinct separation in 𝑅𝐵𝐸𝑚𝑖𝑛 values for Cluster 5, compared to the other clusters, 
is clearly explained by the similar separation in 𝛽, as this is used to derive the 𝑅𝐵𝐸𝑚𝑖𝑛 
value mathematically from Equation (10). A similar separation could then be expected 
to be found for the 𝑅𝐵𝐸𝑚𝑎𝑥 value for Cluster 2. Cluster 2 has the highest average 
𝑅𝐵𝐸𝑚𝑎𝑥, but there is a considerably smaller degree of separation from the other 
clusters, when compared with the equivalent separation for the 𝛼 values. This would 
probably be a result of similarly high 𝛼 values in the reference radiation, which could 





 values. However, this 
requires further investigation to be decisively concluded. 
When comparing the final cluster analysis with the previous one, found in Appendix 
B, the first observation is a slightly better silhouette score and predictor importance, 
with almost no difference in AIC. We also observe a singleton cluster containing the 
excluded experiment from Petrovic et al [58]. However, if we consider that a singleton 
cluster is not analytically valuable, and we only consider the other clusters, we observe 
a clear similarity to the final cluster analysis. For the 𝛼 and 𝛽 distribution, we can see 
that one cluster is separate from the others, implying that Cluster 5 in the final analysis 
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is similar to Cluster 4 from the old, and the Cluster 2 in the new analysis is similar to 
Cluster 5 from the old one. A similar comparison of Cluster 1 and Cluster 3 is not 
observed, however, based on the 𝐷𝑚𝑖𝑛 and 𝐿𝐸𝑇𝑑 distributions, it appears that Cluster 1 
and Cluster 3 in the final analysis is a differently divided distribution of the datapoints 
also found in Cluster 1 and Cluster 3 in the old analysis. We also observe similar trends 





, 𝑅𝐵𝐸𝑚𝑎𝑥, and 𝑅𝐵𝐸𝑚𝑖𝑛 distributions.  
5.2 RBE modeling 
From Figure 11 it can be seen that the 𝑅𝐵𝐸𝑚𝑖𝑛 values of all clusters, except for Cluster 
5, revolve around the value of 1. Cluster 5, being the cluster separated furthest from 
the others, due to its high 𝛽 values, suggests that models with mostly high 𝛽 values in 





, also a quality of Cluster 5, should 
not apply the assumption of 𝑅𝐵𝐸𝑚𝑖𝑛 = 1. For models with databases containing mostly 
lower 𝛽 values, however, this assumption seems to be valid. This is also reflected with 
Cluster 5 having the highest fitting variable for the 𝑅𝐵𝐸𝑚𝑖𝑛 refit. Cluster 4 only has a 
slightly lower fitting variable, however, this cluster contained mostly low experimental 
𝐿𝐸𝑇𝑑 values not allowing the model to express the high  𝑅𝐵𝐸𝑚𝑖𝑛 values it predicts in 
the high 𝐿𝐸𝑇𝑑 range. However, the relatively high variation in this data, as given by 
the R-squared value, is an argument against 𝑅𝐵𝐸𝑚𝑖𝑛 = 1. Actually, the clusters 
augmenting most against 𝑅𝐵𝐸𝑚𝑖𝑛 = 1, Cluster 4, and Cluster 5, both have the best R-
squared values as seen in Table 4. The linear fit to the data was generally poorer for 
the 𝑅𝐵𝐸𝑚𝑖𝑛 fit, than the variation for the 𝑅𝐵𝐸𝑚𝑎𝑥 fit, as represented by the lower R-
squared values found in Table 4 and Table 5. 
The fitting variables for 𝑅𝐵𝐸𝑚𝑎𝑥, however, presents a larger range than the fitting 
variables for 𝑅𝐵𝐸𝑚𝑖𝑛. The Cluster 2 model, containing the highest fitting variable, 





 decreases despite the model being represented 
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The poor fit to the experimental data of Cluster 4, as seen in Figure 14, seems to be a 
result of an overload of experimental datapoints with 𝑅𝐵𝐸𝑚𝑎𝑥 values lower than one, 





. Allowing MATLAB to determine the constant 
term based on the data alone could probably fix this problem. 
The size of each cluster is also relevant, as regression analysis often demands a normal 
distribution in the database to which the regression is applied. Small databases, such as 
Cluster 2 and Cluster 5, with 8 and 10 datapoints, respectively, can be hard to argument 
a normal distribution for. With this in mind, RBE models have been created using 
smaller databases, such as the two Tilly models with four and seven datapoints. 
5.3 FLUKA simulation and dose calculations 
Common for all dose distributions, recalculated with an 𝐿𝐸𝑇𝑑-based RBE model, is an 
increasing dose to the distal edge of the SOBP, as a result of a distal increase in LET 
and RBE in the same region. The highest doses calculated with the Cluster 1 and 
Cluster 2 models separated themselves from the other models with their distinctly high 
𝐷𝑚𝑖𝑛 and 𝛼 values, respectively. 
The fact that Cluster 5 displays a similar dose distribution to the unweighted Rørvik 
model is surprising, as the model equations for these models are not very similar. Based 
on the model equations, it would be expected that the Cluster 1 model would present a 
dose distribution most similar to the Rørvik model, such as the RBE distribution shows. 
This may be explained by the higher 𝑅𝐵𝐸𝑚𝑖𝑛 fitting variable for Cluster 5. 
Based on the dose distributions of the different models, it appears that models based 





 values, as seen in Figure 10 and 
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Figure 11, or high 𝐷𝑚𝑖𝑛 values, predict a disproportionally high dose to the distal edge 
of the SOBP. The lowest doses, however, seem to be predicted by models derived from 
low 𝛼, and low 𝐿𝐸𝑇𝑑, databases. 
5.4 Further work 
Given more time, a similar cluster analysis to the one performed on our database would 
be performed on the original databases for the models included in Chapter 4.3, to 
investigate if the fitting variables found in these models would differ notably for their 
clusters. Statistically, this would be more sound, due to a greater number of 
experiments in each database. It is still unclear which variables should ideally be 
included in such an analysis. This analysis was not considered in this thesis, since our 
purpose was to explore potential patterns in a given database for future construction of 
new RBE-models. 
Another option to further investigate the impact of different experimental dose ranges 
could be to refit the cell survival curves from each experiment in our database, by 
excluding datapoints outside certain dose ranges. The purpose of this would be to 
further calculate new 𝛼 and 𝛽 values, which would further be implemented in the upper 




This project applied cluster analysis to investigate relationships between in vitro based 
RBE databases, and the dependencies of the RBE models derived from these data. The 
results presented in this thesis show that the in vitro data can be organized in clusters 
with different properties, leading to different RBE models and estimates. However, the 
clusters had some overlap and were distributed relatively evenly over the range of the 
input variables present in the database. Therefore, the cluster analysis indicates that the 
database used in this work is relatively well balanced and homogeneous. Nevertheless, 





 ratios, predict 
the highest doses, followed by databases of high 𝐷𝑚𝑖𝑛 values. Databases representing 
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Appendix A  
Database and database calculations: 
In Chapter 3.1 the 𝐿𝐸𝑇𝑑 in our database was normalized to Cobalt-60 using the values 
in Table 7. 
Table 7: Values used to normalize 𝐿𝐸𝑇𝑑 values of the database. Where exact values were 







𝐶𝑜60  0.4 
Howard et al [53] 𝐶𝑠137  0.8 
6 𝑀𝑉 0.2 
120 𝑘𝑉𝑝 1.387 
Mairani et al [66] 
200 𝑘𝑉𝑝 1.164 
225 𝑘𝑉𝑝 1.118 
240 𝑘𝑉𝑝 1.092 
250 𝑘𝑉𝑝 1.075 




Appendix B  
Results from the original cluster analysis where the four final experiments were not 
excluded. 
 
Table 8: Mean value for each variable considered in the analysis with accompanying standard 
deviation for each model and for the entire dataset (All clusters), rounded to two decimals. 
This result includes the later excluded datapoints mentioned in chapter 3.2. 
Mean and Standard deviation 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 
All 
clusters 
𝑫𝐦𝐢𝐧 [𝑮𝒚] 0.86 ± 0.53 8.02 ± 0 0.66 ± 0.44 0.34 ± 0.17 0.44 ± 0.37 0.75 ± 0.88 







1.04 ± 0 2.22 ± 1.74 
15.66
± 3.23 
9.33 ± 5.80 0.88 ± 6.20 








17.10 ± 0 4.15 ± 5.25 3.29 ± 0.67 
11.19
± 5.24 
6.15 ± 8.45 




1.75 ± 0 2.06 ± 5.39 1.66 ± 2.02 2.49 ± 1.53 2.96 ± 8.66 
 
We observe from Figure 19 that the AIC is lowest at 5 clusters, also in this analysis, 
and even though 6, 7 and, 8 clusters all gave a slightly better Silhouette score, a 5 
cluster model was chosen here as well. This was also the number of clusters chosen 






Figure 19: The loss of information as a function of the number of clusters, calculated using 
Bayesian Information Criterion (Blue) and Akaike Information Criterion (Red), respectively. 
The Silhouette scores for 2-15 clusters are also depicted as Green bars. This result 
includes the later excluded datapoints mentioned in chapter 3.2. 
 
 
Figure 20: Predictor Importance for each of the input variables, for a 5-cluster model. This 




From Figure 20 we observe a preferable Predictor importance to the one presented in 
the final analysis. The lowest Predictor importance value was here still over 0.8, for 𝛼, 
and the order was slightly changed as 𝐷𝑚𝑖𝑛 and 𝛽 switched places. The same was 
observed for 𝐿𝐸𝑇𝑑 and 𝛼. 
 
 
Figure 21: Cluster comparison of input variables. All datapoints in each cluster are shown 
as dots for each input variable, with mean value marked as a circle with error bars of ± one 
standard deviation of the mean. Input variables are listed from top to bottom by decreasing 







Figure 22: Cluster comparison of evaluation fields. All datapoints in each cluster are shown 
as dots for each input variable, with mean value marked as a circle with error bars of ± one 
standard deviation of the mean. Input variables are listed from top to bottom by decreasing 





Appendix C  
Model equations: Existing models. 
The McNamara model: 
The McNamara model can be described by the following equations [31, 81, 83]: 




































The Mairani model: 
The Mairani model considering only protons can be described by the following 
equations [31, 82]: 

















A constant 𝑅𝐵𝐸𝑚𝑖𝑛 = 1 was assumed for this model. 
 
The Wilkens and Oelfke model: 












Where 𝜆 is a linear parameter fitting the equation to experimental data. By assuming 
𝛼𝑥 = 0.112𝐺𝑦
−1 and 𝛽𝑥 = 0.0298𝐺𝑦
−2, which was assumed in the paper that 
suggested the model, the resulting model equation can be written as [31]: 






A constant 𝑅𝐵𝐸𝑚𝑖𝑛 = 1 was assumed for this model. 
 
The Peeler model: 
The Peeler model can be described by the following equations [31, 83]: 




































The Wedenberg model: 
The Wedenberg model can be described by the following equation [31, 79, 83]: 




















By restricting the database, and thus limiting the 𝐿𝐸𝑇𝑑 to 20
𝑘𝑒𝑉
𝜇𝑚
 , the fitting variable is 






A constant 𝑅𝐵𝐸𝑚𝑖𝑛 = 1 was assumed for this model. 
 
The unweighted linear Rørvik model: 
The unweighted linear Rørvik model can be described by the following equation [25, 
31]: 
















𝐿𝐸𝑇𝑑  (44) 
A constant 𝑅𝐵𝐸𝑚𝑖𝑛 = 1 was assumed for this model. 
 
The Tilly models: 





= 2 𝐺𝑦 model is given as [31, 67]: 
















𝐿𝐸𝑇𝑑  (45) 
 




































Appendix D  
A short description of the scripts used in Chapter 3.5. 
Table 9: Description of the scripts used in the FLUKA MC simulation process. 
Script Description Provided by 
Sort_dicom.py Converts the DICOM files from 




Convert_to_dicom.py Converts the output files from the 
FLUKA MC simulations into 
DICOM files where dose, LET and 
RBE distribution are calculated. 
Plot_dicom.py Plots the DICOM files from the 
convert_to_dicom.py script into 
2D plots. 
Plot_1d_dicom.py Plots the DICOM files from the 
convert_to_dicom.py script into 
1D plots 
Dose_RT_to_DVH_1.1.py Converts the information from the 
DICOM files from the 
convert_to_dicom.py script into 
text files with DVH information. 
Helge Henjum 
Plot_DVH.py Plots the DVHs based on the 







Appendix E  
FLUKA simulation and dose calculations 
The 𝐿𝐸𝑇𝑑 was increasing towards the distal edge of the SOBP. 
 
Figure 23: 𝐿𝐸𝑇𝑑 distribution based on the scoring file created in the FLUKA simulation. 
 
 
